After completion of abdominal aortic graft, 29 patients received an i.v. infusion of placebo (n = 16) or clonidine 7 micrograms kg-1 (n = 13) over 120 min in a double-blind study. Cardiovascular variables were measured and plasma samples obtained up to 5 h after arrival in the recovery room, for assay of noradrenaline, adrenaline, vasopressin and renin concentrations. Noradrenaline, adrenaline and vasopressin concentrations decreased in the clonidine group throughout recovery (P less than 0.001, 0.05 and 0.05, respectively, vs placebo). Heart rate was less in the clonidine group (P less than 0.01). There was no significant difference in mean arterial pressure between groups. Stroke volume was larger (P less than 0.01) and there were fewer episodes of hypertension (P less than 0.05) and tachycardia in the clonidine group. In addition, a reduction in the number of circulatory interventions (P less than 0.05) and episodes of shivering was noted in the clonidine group. Mean (SD) postoperative volume requirements were larger in the clonidine group (total postoperative input: clonidine 1462 (604) ml; placebo 1064 (348) ml (P less than 0.05]. These data are consistent with the observation that clonidine modifies endocrine and circulatory status after major surgery.

Twenty‐eight patients presenting for aortic surgery were randomly assigned in a double‐blind, placebo‐controlled protocol to receive placebo (n=14) or clonidine (4.7 ± 1.2 μg · kg‐1po; n=14), in addition to flunitrazepam 120 min before induction of anesthesia. Plasma catecholamines (CA) and hemodynamic variables were determined at 7 stages during surgery. In the placebo group, plasma epinephrine (E) and norepinephrine (NE) had risen twofold at skin closure compared to baseline (E: from 109 ± 51 pg p ml‐1to 294 ± 161 pg · ml‐1; NE: from 658 ± 226 to 1150 ± 494 pg · ml‐1). Plasma CA were significantly lower in the clonidine group (P<0.001 and 0.01 vs placebo for NE and E respectively). In both groups, similar directional changes were observed for the circulatory variables, upon aortic clamping and declamping. In the clonidine group, however, mean arterial pressure was lower at most stages (P<0.05 vs placebo); moreover, stroke volume index was greater in the clonidine group (P>0.05) upon declamping. This improved stability in the clonidine group was achieved with a halving in the number of anesthetic/circulatory interventions (P>0.05 vs placebo). Provided intravascular volume is adequate, clonidine suppresses the increase in plasma catecholamines induced by aortic surgery and improves circulatory stability, with a reduced number of anesthetic/ circulatory adjustments.

Bronchial responsiveness to various drug stimuli is currently studied by constructing cumulative dose-response curves of specific respiratory conductance (SG). Airway conductance can be measured in guinea pigs by the plethysmographic technique, during the rapid transition from expiration to inspiration (TEI). Since the drug action assigns a strict timing to the experiment, conventional methods of measuring SG prove inconvenient and often lack accuracy. A computerized data acquisition system has therefore been developed to recognize TEI and calculate SG in real time. This paper describes the significant features of the program DOREMI, and gives an illustrative example of the system in use.

Intravenous infusion of histamine has been shown to constrict smooth muscle of alveolar ducts. In this study, we have assessed the effects of a prolonged infusion of histamine to obtain a steady state response on quasistatic pressure-volume curves (P-V curves) together with the changes in dynamic compliance (Cdyn) and conductance (G) of the respiratory system. Increasing doses of histamine were given in order to obtain the dose-response characteristics of the changes in Cdyn, G and P-V curves. In nine anesthetized guinea-pigs under mechanical ventilation, administration of histamine resulted in a fall in Cdyn and G with a decrease of 50% of initial value approximately for 150 ng X kg-1 X s-1 of histamine. Modifications of the P-V curves were characterized by a decrease in the maximal volume, and an increase in the hysteresis of the P-V loop due to the downward displacement of the inflation limb. With infusion of histamine, there was a large decrease of quasi-static compliance which appeared to account for most of the decrease in dynamic compliance. Such changes in P-V curves can be related both to a closure of alveolar ducts and to an alteration of lung distensibility. Comparison of the dose-response curves for the different parameters indicated that Cdyn and G reflect, at least in part, events occurring in the periphery of the lung.

Plasma histamine in 8 normal subjects was measured before and after inhalation of carbachol to induce a 50% fall in specific airway conductance (SGaw). The measurements were repeated 5 min after inhalation of salbutamol or placebo. No significant change in plasma histamine occurred after placebo or carbachol inhalation, despite the persistent induced bronchospasm after the latter treatment. In contrast, plasma histamine was significantly increased from 0.25 to 0.43 ng/ml after salbutamol inhalation. Simultaneously, induced bronchospasm was relieved, from 51% to 103% of baseline SGaw. Thus, the relief of carbachol-induced bronchospasm by salbutamol was associated with a rise in plasma histamine. Since salbutamol itself is a potent inhibitor of mast cell degranulation and histamine release, the present findings suggest that histamine may be released and sequestered within the lungs during carbachol-induced-bronchospasm, and also that desequestration of bronchoconstrictor mediators accumulated at the point of contact of bronchial smooth muscle may contribute to the relief of bronchospasm by salbutamol.

To determine (1) whether changes in plasma histamine occurred during provoked bronchospasm and (2) if so, whether such changes could be related to variations in plasma catecholamines, venous plasma histamine and catecholamines were measured during a dose-response carbachol challenge in eight healthy volunteers. A significant rise in plasma histamine was observed, whereas induced bronchoconstriction was small, 80% +/- 4% of initial specific airway conductance. There was no further increase in plasma histamine, whereas induced bronchoconstriction became more marked (70%, 60%, and 50% of specific airway conductance initial value). Plasma catecholamines did not change throughout the study. We conclude that mast cell degranulation occurs during a carbachol challenge, and that the variations in plasma histamine are not related to changes in plasma catecholamines.